Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

J&J Q3 Net Profit Slips; Revises 2012 Adj. EPS View - Quick Facts

RELATED NEWS
Trade JNJ now with 

Johnson & Johnson (JNJ: Quote) posted a decline in third-quarter net earnings attributable to the company to $2.97 billion, or $1.05 per share, from $3.20 billion, or $1.15 per share a year before.

However, excluding items, quarterly adjusted earnings totaled $3.52 billion, or $1.25 per share, higher than $3.44 billion, or $1.24 per share last year. On average, 16 analysts polled by Thomson Reuters expected earnings per share of $1.21 for the quarter. Analysts' estimates typically exclude one-time items.

Sales to customers were $17.1 billion for the 2012 third quarter, up 6.5% as compared with last year's $16.0 billion, while 13 analysts estimated revenues of $16.95 billion for the quarter. Operational results went up 10.8% and the negative impact of currency was 4.3%. Domestic sales increased 13.4%. International sales rose by 1.4%, reflecting operational growth of 8.9% and a negative currency impact of 7.5%.

For full year 2012, the company now sees earnings of $5.05 - $5.10 per share, excluding the impact of special items. Twenty analysts project annual earnings of $5.06 per share.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.